Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-25-008770

Chief Scientific Officer gave up 6,826 shares (to pay taxes)

  • Chief Scientific Officer acquired 3,184 shares (grant or award)
  • Chief Scientific Officer acquired 23,216 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-30 Exercise or conversion : show line 1 in the form +9,275 62,921 D
2025-01-30 Shares withheld for taxes : show line 2 in the form −2,709 $7.00 $18,963 60,212 D
2025-01-31 Grant or award : show line 3 in the form +3,184 $5.18 $16,493 63,396 D
2025-02-01 Exercise or conversion : show line 4 in the form +6,166 69,562 D
2025-02-01 Shares withheld for taxes : show line 5 in the form −1,801 $6.64 $11,959 67,761 D
2025-02-02 Exercise or conversion : show line 6 in the form +7,775 75,536 D
2025-02-02 Shares withheld for taxes : show line 7 in the form −2,316 $6.64 $15,378 73,220 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-01-30 Exercise or conversion : show line 8 in the form Restricted Stock Units +9,275 18,550 D
2025-02-01 Exercise or conversion : show line 9 in the form Restricted Stock Units +6,166 0 D
2025-02-02 Exercise or conversion : show line 10 in the form Restricted Stock Units +7,775 7,775 D
Loading xslF345X05/tm255357-1_4seq1.xml…